Related references
Note: Only part of the references are listed.Synergistic anticancer effect of rAd/P53 combined with 5-fluorouracil or iodized oil in the early therapeutic response of human colon cancer in vivo
Qi Xie et al.
GENE (2012)
Evaluation of Fbxw7 expression and its correlation with the expression of c-Myc, cyclin E and p53 in human hepatocellular carcinoma
Kangsheng Tu et al.
HEPATOLOGY RESEARCH (2012)
Clinical Impact of NOTCH1 and/or FBXW7 Mutations, FLASH Deletion, and TCR Status in Pediatric T-Cell Lymphoblastic Lymphoma
Celine Callens et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
The two faces of FBW7 in cancer drug resistance
Zhiwei Wang et al.
BIOESSAYS (2011)
Reduced expression of ubiquitin ligase FBXW7 mRNA is associated with poor prognosis in breast cancer patients
Mutsuko Ibusuki et al.
CANCER SCIENCE (2011)
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7
Ingrid E. Wertz et al.
NATURE (2011)
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
K. M. Crusio et al.
ONCOGENE (2010)
p53-Altered FBXW7 Expression Determines Poor Prognosis in Gastric Cancer Cases
Takehiko Yokobori et al.
CANCER RESEARCH (2009)
In vitro and Clinical Studies of Gene Therapy with Recombinant Human Adenovirus-p53 Injection for Oral Leukoplakia
Yi Li et al.
CLINICAL CANCER RESEARCH (2009)
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Markus Welcker et al.
NATURE REVIEWS CANCER (2008)
FBXW7/hCDC4 is a general tumor suppressor in human cancer
Shahab Akhoondi et al.
CANCER RESEARCH (2007)
Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer
EL Kwak et al.
GYNECOLOGIC ONCOLOGY (2005)
Cyclin E in normal and neoplastic cell cycles
HC Hwang et al.
ONCOGENE (2005)
Current status of gendicine in China: Recombinant human Ad-p53 agent for treatment of cancers
ZH Peng
HUMAN GENE THERAPY (2005)
Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
JH Mao et al.
NATURE (2004)
Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7
M Yada et al.
EMBO JOURNAL (2004)
Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line
H Strohmaier et al.
NATURE (2001)
Share Paper
